The herpesvirus stealth program
The herpesvirus stealth program |
https://doi.org/10.18632/oncotarget.5261
Teng Huang,
and Nikolaus Osterrieder
|
21761-21762 |
LOX-1 boosts immunity |
https://doi.org/10.18632/oncotarget.4756
SangKon Oh,
and HyeMee Joo
|
21763-21764 |
Fatty acid synthesis and NLRP3-inflammasome
Fatty acid synthesis and NLRP3-inflammasome |
https://doi.org/10.18632/oncotarget.4781
Jong-Seok Moon,
Kiichi Nakahira,
and Augustine M.K. Choi
|
21765-21766 |
A Hrd way for MHC-II expression
A Hrd way for MHC-II expression |
https://doi.org/10.18632/oncotarget.4799
Johanna Melo-Cardenas,
Sinyi Kong,
and Deyu Fang
|
21767-21768 |
Complementing regeneration
Complementing regeneration |
https://doi.org/10.18632/oncotarget.4844
Ali Alawieh,
Aarti Narang,
and Stephen Tomlinson
|
21769-21770 |
IDO-GCN2 and autophagy in inflammation
IDO-GCN2 and autophagy in inflammation |
https://doi.org/10.18632/oncotarget.4846
Tracy L. McGaha
|
21771-21772 |
TCR signals fuel Treg cells
TCR signals fuel Treg cells |
https://doi.org/10.18632/oncotarget.4881
Christoph Drees,
J. Christoph Vahl,
and Marc Schmidt-Supprian
|
21773-21774 |
IL-37 restrains autoimmune diseases
IL-37 restrains autoimmune diseases |
https://doi.org/10.18632/oncotarget.4887
Liang Ye,
and Huang Zhong
|
21775-21776 |
Thymic involution beyond T-cell insufficiency
Thymic involution beyond T-cell insufficiency |
https://doi.org/10.18632/oncotarget.4970
Brandon Coder,
and Dong-Ming Su
|
21777-21778 |
OX40/OX40L axis: not a friend in autoimmunity
OX40/OX40L axis: not a friend in autoimmunity |
https://doi.org/10.18632/oncotarget.4973
Hideki Ueno,
and Patrick Blanco
|
21779-21780 |
Protein conformation in a vaccine matters
Protein conformation in a vaccine matters |
https://doi.org/10.18632/oncotarget.5102
Trudy G. Morrison
|
21781-21782 |
PD-1: Dual guard for immunopathology
PD-1: Dual guard for immunopathology |
https://doi.org/10.18632/oncotarget.4787
Hye Ryun Kim,
Hyo Jin Park,
and Sang-Jun Ha
|
21783-21784 |
Regulation of T follicular helper cells by ICOS
Regulation of T follicular helper cells by ICOS |
https://doi.org/10.18632/oncotarget.4798
Andreas Hutloff
|
21785-21786 |
Notch controls effector CD8+ T cell differentiation
Notch controls effector CD8+ T cell differentiation |
https://doi.org/10.18632/oncotarget.4886
Frédéric Duval,
Mélissa Mathieu,
and Nathalie Labrecque
|
21787-21788 |
TPL2 mediates IL-17R signaling in neuroinflammation
TPL2 mediates IL-17R signaling in neuroinflammation |
https://doi.org/10.18632/oncotarget.4888
Yichuan Xiao,
and Shao-Cong Sun
|
21789-21790 |
Uncovering HIV-1-infected cells
Uncovering HIV-1-infected cells |
https://doi.org/10.18632/oncotarget.4974
Maxime Veillette,
Jonathan Richard,
and Andrés Finzi
|
21791-21792 |
RUNX1 as a recombinase cofactor
RUNX1 as a recombinase cofactor |
https://doi.org/10.18632/oncotarget.5488
Agata Cieslak,
Dominique Payet-Bornet,
and Vahid Asnafi
|
21793-21794 |
Natural Th1 cells: escape from neglect
Natural Th1 cells: escape from neglect |
https://doi.org/10.18632/oncotarget.5489
Seong Hoe Park
|
21795-21796 |
NK cell exhaustion: bad news for chronic disease?
NK cell exhaustion: bad news for chronic disease? |
https://doi.org/10.18632/oncotarget.5490
Jamie L. Schafer,
Michaela C. Müller-Trutwin,
and R. Keith Reeves
|
21797-21798 |
Cdk5 and Foxc2 – a new relationship in the lymphatic vasculature
Cdk5 and Foxc2 – a new relationship in the lymphatic vasculature |
https://doi.org/10.18632/oncotarget.4848
Johanna Liebl
|
21799-21801 |
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 |
https://doi.org/10.18632/oncotarget.5224
Ri Cui,
Taewan Kim,
Matteo Fassan,
Wei Meng,
Hui-Lung Sun,
Young-Jun Jeon,
Caterina Vicentini,
Esmerina Tili,
Yong Peng,
Aldo Scarpa,
Guang Liang,
Yong Kui Zhang,
Arnab Chakravarti,
and Carlo M. Croce
|
21802-21815 |
Perifosine as a potential novel anti-telomerase therapy
Perifosine as a potential novel anti-telomerase therapy |
https://doi.org/10.18632/oncotarget.5200
Brody Holohan,
Moriah M. Hagiopian,
Tsung-Po Lai,
Ejun Huang,
Daphne R. Friedman,
Woodring E. Wright,
and Jerry W. Shay
|
21816-21826 |
In vivo hematopoietic Myc activation directs a transcriptional signature in endothelial cells within the bone marrow microenvironment
In vivo hematopoietic Myc activation directs a transcriptional signature in endothelial cells within the bone marrow microenvironment |
https://doi.org/10.18632/oncotarget.5217
Katharina Franke,
Baiba Vilne,
Olivia Prazeres da Costa,
Martina Rudelius,
Christian Peschel,
Robert A.J. Oostendorp,
and Ulrich Keller
|
21827-21839 |
Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy |
https://doi.org/10.18632/oncotarget.4808
Kei Miyakawa,
Satoko Matsunaga,
Koichi Watashi,
Masaya Sugiyama,
Hirokazu Kimura,
Naoki Yamamoto,
Masashi Mizokami,
Takaji Wakita,
and Akihide Ryo
|
21840-21852 |
Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis
Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis |
https://doi.org/10.18632/oncotarget.5213
Trine B. Levring,
Martin Kongsbak,
Anna K. O. Rode,
Anders Woetmann,
Niels Ødum,
Charlotte Menné Bonefeld,
and Carsten Geisler
|
21853-21864 |
The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways
The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways |
https://doi.org/10.18632/oncotarget.4156
Mounia Guerram,
Zhen-Zhou Jiang,
Bashir Alsiddig Yousef,
Aida Mejda Hamdi,
Hozeifa Mohamed Hassan,
Zi-Qiao Yuan,
Hou-Wei Luo,
Xiong Zhu,
and Lu-Yong Zhang
|
21865-21877 |
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer |
https://doi.org/10.18632/oncotarget.4243
Luca Magnani,
Darren K. Patten,
Van T. M. Nguyen,
Sung-Pil Hong,
Jennifer H. Steel,
Naina Patel,
Ylenia Lombardo,
Monica Faronato,
Ana R. Gomes,
Laura Woodley,
Karen Page,
David Guttery,
Lindsay Primrose,
Daniel Fernandez Garcia,
Jacqui Shaw,
Patrizia Viola,
Andrew Green,
Christopher Nolan,
Ian O. Ellis,
Emad A. Rakha,
Sami Shousha,
Eric W.-F. Lam,
Balázs Győrffy,
Mathieu Lupien,
and Charles R. Coombes
|
21878-21891 |
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells |
https://doi.org/10.18632/oncotarget.5260
Rebecca Lamb,
Bela Ozsvari,
Gloria Bonuccelli,
Duncan L. Smith,
Richard G. Pestell,
Ubaldo E. Martinez-Outschoorn,
Robert B. Clarke,
Federica Sotgia,
and Michael P. Lisanti
|
21892-21905 |
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling |
https://doi.org/10.18632/oncotarget.4259
Yulei Zhao,
and Xiaolong Yang
|
21906-21917 |
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 |
https://doi.org/10.18632/oncotarget.4204
Simona Taverna,
Marco Giallombardo,
Marzia Pucci,
Anna Flugy,
Mauro Manno,
Samuele Raccosta,
Christian Rolfo,
Giacomo De Leo,
and Riccardo Alessandro
|
21918-21933 |
Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326
Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 |
https://doi.org/10.18632/oncotarget.4290
Jing Ke,
Yi-long Yao,
Jian Zheng,
Ping Wang,
Yun-hui Liu,
Jun Ma,
Zhen Li,
Xiao-bai Liu,
Zhi-qing Li,
Zhen-hua Wang,
and Yi-xue Xue
|
21934-21949 |
Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis
Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis |
https://doi.org/10.18632/oncotarget.4277
Sabrina Daniela da Silva,
Fabio Albuquerque Marchi,
Bin Xu,
Krikor Bijian,
Faisal Alobaid,
Alex Mlynarek,
Silvia Regina Rogatto,
Michael Hier,
Luiz Paulo Kowalski,
and Moulay A. Alaoui-Jamali
|
21950-21963 |
DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers
DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers |
https://doi.org/10.18632/oncotarget.4157
Tarek M.A. Abdel-Fatah,
Arvind Arora,
Paul M. Moseley,
Christina Perry,
Emad A. Rakha,
Andrew R. Green,
Stephen Y.T. Chan,
Ian O. Ellis,
and Srinivasan Madhusudan
|
21964-21978 |
Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness
Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness |
https://doi.org/10.18632/oncotarget.4273
Chien-Wei Lee,
Kai-Ping Chang,
Yan-Yu Chen,
Ying Liang,
Chuen Hsueh,
Jau-Song Yu,
Yu-Sun Chang,
and Chia-Jung Yu
|
21979-21992 |
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy |
https://doi.org/10.18632/oncotarget.4014
Tsun-Wen Yao,
Jie Zhang,
Michael Prados,
William A. Weiss,
C. David James,
and Theodore Nicolaides
|
21993-22005 |
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species |
https://doi.org/10.18632/oncotarget.4292
Wei Yang,
Yueming Shen,
Jing Wei,
and Fenju Liu
|
22006-22027 |
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer |
https://doi.org/10.18632/oncotarget.4314
Anna Karlsson,
Hans Brunnström,
Kajsa Ericson Lindquist,
Karin Jirström,
Mats Jönsson,
Frida Rosengren,
Christel Reuterswärd,
Helena Cirenajwis,
Åke Borg,
Per Jönsson,
Maria Planck,
Göran Jönsson,
and Johan Staaf
|
22028-22037 |
‘Cut from the same cloth’: Shared microsatellite variants among cancers link to ectodermal tissues-neural tube and crest cells
‘Cut from the same cloth’: Shared microsatellite variants among cancers link to ectodermal tissues-neural tube and crest cells |
https://doi.org/10.18632/oncotarget.4194
Enusha Karunasena,
Lauren J. McIver,
Jasmin H. Bavarva,
Xiaowei Wu,
Hongxiao Zhu,
and Harold R. Garner
|
22038-22047 |
A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis
A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis |
https://doi.org/10.18632/oncotarget.4218
Jong-Min Lee,
Kyoung-Won Cho,
Eun-Jung Kim,
Qinghuang Tang,
Kye-Seong Kim,
Cheryll Tickle,
and Han-Sung Jung
|
22048-22059 |
Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass
Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass |
https://doi.org/10.18632/oncotarget.4279
Chih-Cheng Yang,
Ladan Fazli,
Salvatore Loguercio,
Irina Zharkikh,
Pedro Aza-Blanc,
Martin E. Gleave,
and Dieter A. Wolf
|
22060-22071 |
Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer
Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.4299
Long Jiang,
Shanshan Jiang,
Yongbin Lin,
Han Yang,
Zerui Zhao,
Zehua Xie,
Yaobin Lin,
and Hao Long
|
22072-22080 |
Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression
Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression |
https://doi.org/10.18632/oncotarget.4203
María Laura Polo,
Marina Riggio,
María May,
María Jimena Rodríguez,
María Cecilia Perrone,
Melody Stallings-Mann,
Diego Kaen,
Marlene Frost,
Matthew Goetz,
Judy Boughey,
Claudia Lanari,
Derek Radisky,
and Virginia Novaro
|
22081-22097 |
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120) |
https://doi.org/10.18632/oncotarget.4300
Ruby Yun-Ju Huang,
Kuee Theng Kuay,
Tuan Zea Tan,
Mohammad Asad,
Hei Mui Tang,
Aloysius Hsien Chun Ng,
Jieru Ye,
Vin Yee Chung,
and Jean Paul Thiery
|
22098-22113 |
Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy
Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy |
https://doi.org/10.18632/oncotarget.4294
Kei Mitsuhashi,
Itaru Yamamoto,
Hiroyoshi Kurihara,
Shinichi Kanno,
Miki Ito,
Hisayoshi Igarashi,
Keisuke Ishigami,
Yasutaka Sukawa,
Mami Tachibana,
Hiroaki Takahashi,
Takashi Tokino,
Reo Maruyama,
Hiromu Suzuki,
Kohzoh Imai,
Yasuhisa Shinomura,
Hiroyuki Yamamoto,
and Katsuhiko Nosho
|
22114-22125 |
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth |
https://doi.org/10.18632/oncotarget.4244
Yan Dong,
Baoping Cao,
Meiying Zhang,
Weidong Han,
James G. Herman,
François Fuks,
Yali Zhao,
and Mingzhou Guo
|
22126-22138 |
Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression
Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression |
https://doi.org/10.18632/oncotarget.4192
Hye Lim Lee,
Mi Hee Park,
Dong Ju Son,
Ho Sub Song,
Jung Hyun Kim,
Seong Cheol Ko,
Min Jong Song,
Won Hyoung Lee,
Joo Hee Yoon,
Young Wan Ham,
Sang Bae Han,
and Jin Tae Hong
|
22139-22151 |
Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle
Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle |
https://doi.org/10.18632/oncotarget.4158
Ly-Thuy-Tram Le,
Morgane Couvet,
Bertrand Favier,
Jean-Luc Coll,
Chi-Hung Nguyen,
and Annie Molla
|
22152-22166 |
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1 |
https://doi.org/10.18632/oncotarget.4240
Shuai Lu,
Helga-Paula Török,
Eike Gallmeier,
Frank T. Kolligs,
Antonia Rizzani,
Sabrina Arena,
Burkhard Göke,
Alexander L. Gerbes,
and Enrico N. De Toni
|
22167-22178 |
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels |
https://doi.org/10.18632/oncotarget.4246
Byungho Lim,
Jihyeob Mun,
Jeong-Hwan Kim,
Chan Wook Kim,
Seon Ae Roh,
Dong-Hyung Cho,
Yong Sung Kim,
Seon-Young Kim,
and Jin Cheon Kim
|
22179-22190 |
Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response
Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response |
https://doi.org/10.18632/oncotarget.4339
Stuart J. Smith,
Jennifer H. Ward,
Christopher Tan,
Richard G. Grundy,
and Ruman Rahman
|
22191-22205 |
Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?
Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet? |
https://doi.org/10.18632/oncotarget.4247
Sameh Mikhail,
Kristen Ciombor,
Anne Noonan,
Christina Wu,
Richard Goldberg,
Weiqiang Zhao,
Lai Wei,
Kristina Mathey,
Melissa Yereb,
Cynthia Timmers,
and Tanios Bekaii-Saab
|
22206-22213 |
PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop
PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop |
https://doi.org/10.18632/oncotarget.4257
Michael Selitrennik,
and Sima Lev
|
22214-22226 |
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients |
https://doi.org/10.18632/oncotarget.4276
Xia-Ying Kuang,
Li Chen,
Zhi-Jie Zhang,
Yi-Rong Liu,
Yi-Zi Zheng,
Hong Ling,
Feng Qiao,
Shan Li,
Xin Hu,
and Zhi-Ming Shao
|
22227-22238 |
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma |
https://doi.org/10.18632/oncotarget.4161
Jules Lin,
Amy L. Myers,
Zhuwen Wang,
Derek J. Nancarrow,
Daysha Ferrer-Torres,
Amy Handlogten,
Kimmy Leverenz,
Julia Bao,
Dafydd G. Thomas,
Thomas D. Wang,
Mark B. Orringer,
Rishindra M. Reddy,
Andrew C. Chang,
David G. Beer,
and Lin Lin
|
22239-22257 |
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells |
https://doi.org/10.18632/oncotarget.4165
Steve Dingwall,
Jung Bok Lee,
Borhane Guezguez,
Aline Fiebig,
Jamie McNicol,
Douglas Boreham,
Tony J. Collins,
and Mick Bhatia
|
22258-22269 |
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy |
https://doi.org/10.18632/oncotarget.4207
Mohammad T. Malik,
Martin G. O’Toole,
Lavona K. Casson,
Shelia D. Thomas,
Gina T. Bardi,
Elsa Merit Reyes-Reyes,
Chin K. Ng,
Kyung A. Kang,
and Paula J. Bates
|
22270-22281 |
Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of patched and increase chemotherapy efficiency on melanoma cells
Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of patched and increase chemotherapy efficiency on melanoma cells |
https://doi.org/10.18632/oncotarget.4162
Laura Fiorini,
Marie-Aude Tribalat,
Lucy Sauvard,
Julie Cazareth,
Enzo Lalli,
Isabelle Broutin,
Olivier P. Thomas,
and Isabelle Mus-Veteau
|
22282-22297 |
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma |
https://doi.org/10.18632/oncotarget.4263
Valentina Condelli,
Francesca Maddalena,
Lorenza Sisinni,
Giacomo Lettini,
Danilo Swann Matassa,
Annamaria Piscazzi,
Giuseppe Palladino,
Maria Rosaria Amoroso,
Franca Esposito,
and Matteo Landriscina
|
22298-22309 |
Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F
Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F |
https://doi.org/10.18632/oncotarget.4208
Spela Magister,
Han-Ching Tseng,
Vickie T. Bui,
Janko Kos,
and Anahid Jewett
|
22310-22327 |
Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras
Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras |
https://doi.org/10.18632/oncotarget.4084
Bo Peng,
Suthakar Ganapathy,
Ling Shen,
Junchi Huang,
Bo Yi,
Xiaodong Zhou,
Wei Dai,
and Changyan Chen
|
22328-22337 |
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting NK cell, macrophage and T cell responses
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting NK cell, macrophage and T cell responses |
https://doi.org/10.18632/oncotarget.4169
Katherine T. Morris,
Eliseo F. Castillo,
Anita L. Ray,
Lea L. Weston,
Robert A. Nofchissey,
Joshua A. Hanson,
Von G. Samedi,
Irina V. Pinchuk,
Laurie G. Hudson,
and Ellen J. Beswick
|
22338-22347 |
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma |
https://doi.org/10.18632/oncotarget.4255
Katherine E. Hutchinson,
Douglas B. Johnson,
Adam S. Johnson,
Violeta Sanchez,
Maria Kuba,
Pengcheng Lu,
Xi Chen,
Mark C. Kelley,
Qingguo Wang,
Zhongming Zhao,
Mark Kris,
Michael F. Berger,
Jeffrey A. Sosman,
and William Pao
|
22348-22360 |
CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells |
https://doi.org/10.18632/oncotarget.4293
Norihiko Kawamura,
Keisuke Nimura,
Hiromichi Nagano,
Sohei Yamaguchi,
Norio Nonomura,
and Yasufumi Kaneda
|
22361-22374 |
Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis
Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis |
https://doi.org/10.18632/oncotarget.4296
Joan Manils,
Diana Gómez,
Mercè Salla-Martret,
Heinz Fischer,
Jason M. Fye,
Elena Marzo,
Laura Marruecos,
Inma Serrano,
Rocío Salgado,
Juan P. Rodrigo,
Juana M. Garcia-Pedrero,
Anna M. Serafin,
Xavier Cañas,
Carmen Benito,
Agustí Toll,
Sònia-Vanina Forcales,
Fred W. Perrino,
Leopold Eckhart,
and Concepció Soler
|
22375-22396 |
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine |
https://doi.org/10.18632/oncotarget.4272
Christine Di Cresce,
Rene Figueredo,
Mateusz Rytelewski,
Saman Maleki Vareki,
Colin Way,
Peter J. Ferguson,
Mark D. Vincent,
and James Koropatnick
|
22397-22409 |
MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis
MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis |
https://doi.org/10.18632/oncotarget.4198
Chun-Ting Hu,
Li-Li Guo,
Na Feng,
Lei Zhang,
Na Zhou,
Li-Li Ma,
Lan Shen,
Gui-hui Tong,
Qian-Wen Yan,
Shi-jie Zhu,
Xiu-Wu Bian,
Mao-De Lai,
Yong-Jian Deng,
and Yan-Qing Ding
|
22410-22423 |
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids |
https://doi.org/10.18632/oncotarget.4211
Teresa Peart,
Yudith Ramos Valdes,
Rohann J. M. Correa,
Elena Fazio,
Monique Bertrand,
Jacob McGee,
Michel Préfontaine,
Akira Sugimoto,
Gabriel E. DiMattia,
and Trevor G. Shepherd
|
22424-22438 |
miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD)
miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD) |
https://doi.org/10.18632/oncotarget.4210
Xiaoyong Huang,
Samira Taeb,
Sahar Jahangiri,
Elina Korpela,
Ivan Cadonic,
Nancy Yu,
Sergey Krylov,
Emmanouil Fokas,
Paul C. Boutros,
and Stanley K. Liu
|
22439-22451 |
miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14
miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14 |
https://doi.org/10.18632/oncotarget.4311
Xuan Xiang,
Hong Mei,
Xiang Zhao,
Jiarui Pu,
Dan Li,
Hongxia Qu,
Wanju Jiao,
Jihe Zhao,
Kai Huang,
Liduan Zheng,
and Qiangsong Tong
|
22452-22466 |
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation |
https://doi.org/10.18632/oncotarget.4164
Monica Faronato,
Van T.M. Nguyen,
Darren K. Patten,
Ylenia Lombardo,
Jennifer H. Steel,
Naina Patel,
Laura Woodley,
Sami Shousha,
Giancarlo Pruneri,
R. Charles Coombes,
and Luca Magnani
|
22467-22479 |
Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition
Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition |
https://doi.org/10.18632/oncotarget.4310
Shanmugarajan Krishnan,
Emese Szabo,
Isabel Burghardt,
Karl Frei,
Ghazaleh Tabatabai,
and Michael Weller
|
22480-22495 |
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* |
https://doi.org/10.18632/oncotarget.4318
David M. Goldenberg,
Thomas M. Cardillo,
Serengulam V. Govindan,
Edmund A. Rossi,
and Robert M. Sharkey
|
22496-22512 |
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer |
https://doi.org/10.18632/oncotarget.4154
Wei-Cheng Liang,
Wei-Ming Fu,
Cheuk-Wa Wong,
Yan Wang,
Wei-Mao Wang,
Guo-Xin Hu,
Li Zhang,
Li-Jia Xiao,
David Chi-Cheong Wan,
Jin-Fang Zhang,
and Mary Miu-Yee Waye
|
22513-22525 |
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors |
https://doi.org/10.18632/oncotarget.4151
Barbara Fazi,
Armando Felsani,
Luigi Grassi,
Anna Moles,
Daniel D’Andrea,
Nicola Toschi,
Daria Sicari,
Pasquale De Bonis,
Carmelo Anile,
Maria Giovanna Guerrisi,
Emilia Luca,
Maria Giulia Farace,
Giulio Maira,
Silvia Anna Ciafré,
and Annunziato Mangiola
|
22526-22552 |
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform |
https://doi.org/10.18632/oncotarget.4155
Kathrin Schaal,
Marc Hirschfeld,
Peter Bronsert,
Hannah Füllgraf,
Markus Jäger,
Bettina Herde,
Claudia Nöthling,
Sebastian Mayer,
Thalia Erbes,
and Elmar Stickeler
|
22553-22563 |
Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer |
https://doi.org/10.18632/oncotarget.4197
Yun Luo,
Qi-Wei Jiang,
Jie-Ying Wu,
Jian-Ge Qiu,
Wen-Ji Zhang,
Xiao-Long Mei,
Zhi Shi,
and Jin-Ming Di
|
22564-22574 |
Enhanced nucleotide excision repair capacity in lung cancer cells by preconditioning with DNA-damaging agents
Enhanced nucleotide excision repair capacity in lung cancer cells by preconditioning with DNA-damaging agents |
https://doi.org/10.18632/oncotarget.4610
Ji Ye Choi,
Jeong-Min Park,
Joo Mi Yi,
Sun-Hee Leem,
and Tae-Hong Kang
|
22575-22586 |
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression |
https://doi.org/10.18632/oncotarget.4088
Shibao Li,
Yingyu Ma,
Chongwei Xie,
Zhiyuan Wu,
Zhihua Kang,
Zujun Fang,
Bing Su,
and Ming Guan
|
22587-22597 |
Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis
Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis |
https://doi.org/10.18632/oncotarget.4200
Ping Wang,
Peiguo Wang,
Becky Liu,
Jing Zhao,
Qingsong Pang,
Samir G. Agrawal,
Li Jia,
and Feng-Ting Liu
|
22598-22612 |
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model |
https://doi.org/10.18632/oncotarget.4209
Adi Binder Gallimidi,
Stuart Fischman,
Brurya Revach,
Raanan Bulvik,
Alina Maliutina,
Ariel M. Rubinstein,
Gabriel Nussbaum,
and Michael Elkin
|
22613-22623 |
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells |
https://doi.org/10.18632/oncotarget.4168
Silvia Bruno,
Bernardetta Ledda,
Claudya Tenca,
Silvia Ravera,
Anna Maria Orengo,
Andrea Nicola Mazzarello,
Elisa Pesenti,
Salvatore Casciaro,
Omar Racchi,
Fabio Ghiotto,
Cecilia Marini,
Gianmario Sambuceti,
Andrea DeCensi,
and Franco Fais
|
22624-22640 |
Role of PAR-4 in ovarian cancer
Role of PAR-4 in ovarian cancer |
https://doi.org/10.18632/oncotarget.4010
Sonia Meynier,
Marianne Kramer,
Pascale Ribaux,
Jean Christophe Tille,
Florence Delie,
Patrick Petignat,
and Marie Cohen
|
22641-22652 |
The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis |
https://doi.org/10.18632/oncotarget.4248
Richard L. Carpenter,
Ivy Paw,
Hu Zhu,
Sherona Sirkisoon,
Fei Xing,
Kounosuke Watabe,
Waldemar Debinski,
and Hui-Wen Lo
|
22653-22665 |
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.4433
Christophe Deben,
An Wouters,
Ken Op de Beeck,
Jolien van Den Bossche,
Julie Jacobs,
Karen Zwaenepoel,
Marc Peeters,
Jan Van Meerbeeck,
Filip Lardon,
Christian Rolfo,
Vanessa Deschoolmeester,
and Patrick Pauwels
|
22666-22679 |
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop |
https://doi.org/10.18632/oncotarget.4205
Nis David Giladi,
Amotz Ziv-Av,
Hae Kyung Lee,
Susan Finniss,
Simona Cazacu,
Cunli Xiang,
Hiba Ben-Asher,
Ana deCarvalho,
Tom Mikkelsen,
Laila Poisson,
and Chaya Brodie
|
22680-22697 |
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy |
https://doi.org/10.18632/oncotarget.4245
Toril Holien,
Kristine Misund,
Oddrun Elise Olsen,
Katarzyna Anna Baranowska,
Glenn Buene,
Magne Børset,
Anders Waage,
and Anders Sundan
|
22698-22705 |
Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target
Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target |
https://doi.org/10.18632/oncotarget.4256
Qianling Liu,
Jie Jin,
Jianming Ying,
Yun Cui,
Mengkui Sun,
Lian Zhang,
Yu Fan,
Ben Xu,
and Qian Zhang
|
22706-22723 |
Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma
Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma |
https://doi.org/10.18632/oncotarget.4261
Gabriela Resende Vieira de Sousa,
Tamaya C. Ribeiro,
Andre M. Faria,
Beatriz M. P. Mariani,
Antonio M. Lerario,
Maria Claudia N. Zerbini,
Iberê C. Soares,
Alda Wakamatsu,
Venancio A. F. Alves,
Berenice B. Mendonca,
Maria Candida B. V. Fragoso,
Ana Claudia Latronico,
and Madson Q. Almeida
|
22724-22733 |
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia |
https://doi.org/10.18632/oncotarget.4212
Sílvia Xargay-Torrent,
Mónica López-Guerra,
Laia Rosich,
Arnau Montraveta,
Jocabed Roldán,
Vanina Rodríguez,
Neus Villamor,
Marta Aymerich,
Chandraiah Lagisetti,
Thomas R. Webb,
Carlos López-Otín,
Elias Campo,
and Dolors Colomer
|
22734-22749 |
A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer
A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer |
https://doi.org/10.18632/oncotarget.4262
Ke-Jun Liu,
and Hai-Ying Wu
|
22750-22757 |
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition |
https://doi.org/10.18632/oncotarget.4283
Jared J. Barrott,
Benjamin E. Illum,
Huifeng Jin,
Ju-Fen Zhu,
Tim Mosbruger,
Michael J. Monument,
Kyllie Smith-Fry,
Matthew G. Cable,
Yanliang Wang,
Allie H. Grossmann,
Mario R. Capecchi,
and Kevin B. Jones
|
22758-22766 |
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression |
https://doi.org/10.18632/oncotarget.4082
Xin Tian,
Shundong Dai,
Jing Sun,
Guojiang Jin,
Shenyi Jiang,
Fandong Meng,
Yan Li,
Di Wu,
and Youhong Jiang
|
22767-22775 |
Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis
Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis |
https://doi.org/10.18632/oncotarget.4309
Maciej Nowacki,
Marek Wisniewski,
Karolina Werengowska-Ciecwierz,
Katarzyna Roszek,
Joanna Czarnecka,
I. Łakomska,
Tomasz Kloskowski,
Dominik Tyloch,
Robert Debski,
Katarzyna Pietkun,
Marta Pokrywczynska,
Dariusz Grzanka,
Rafał Czajkowski,
Gerard Drewa,
A. Jundziłł,
Joseph K. Agyin,
Samy L. Habib,
Artur P. Terzyk,
and Tomasz Drewa
|
22776-22798 |
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3 |
https://doi.org/10.18632/oncotarget.4332
Baolai Zhang,
Shuhong Dong,
Ruiming Zhu,
Chunyan Hu,
Jing Hou,
Yan Li,
Qian Zhao,
Xue Shao,
Qian Bu,
Hongyu Li,
Yongjie Wu,
Xiaobo Cen,
and Yinglan Zhao
|
22799-22811 |
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.4333
Jean-Emmanuel Bibault,
Martin Figeac,
Nathalie Hélevaut,
Céline Rodriguez,
Sabine Quief,
Shéhérazade Sebda,
Aline Renneville,
Olivier Nibourel,
Philippe Rousselot,
Bérengère Gruson,
Hervé Dombret,
Sylvie Castaigne,
and Claude Preudhomme
|
22812-22821 |
Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma
Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma |
https://doi.org/10.18632/oncotarget.4477
Daiki Mochizuki,
April Adams,
Kristy A. Warner,
Zhaocheng Zhang,
Alexander T. Pearson,
Kiyoshi Misawa,
Scott A. McLean,
Gregory T. Wolf,
and Jacques E. Nör
|
22822-22835 |
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation |
https://doi.org/10.18632/oncotarget.4479
Isabel R. Schlaepfer,
Dhanya K. Nambiar,
Anand Ramteke,
Rahul Kumar,
Deepanshi Dhar,
Chapla Agarwal,
Bryan Bergman,
Michael Graner,
Paul Maroni,
Rana P. Singh,
Rajesh Agarwal,
and Gagan Deep
|
22836-22856 |
Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma
Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma |
https://doi.org/10.18632/oncotarget.3127
Muly Tham,
Karen Khoo,
Kim Pin Yeo,
Masashi Kato,
Amelle Prevost-Blondel,
Veronique Angeli,
and Jean-Pierre Abastado
|
22857-22868 |
p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin
p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin |
https://doi.org/10.18632/oncotarget.5137
Xinbing Sui,
Jing Zhu,
Haimei Tang,
Chan Wang,
Jichun Zhou,
Weidong Han,
Xian Wang,
Yong Fang,
Yinghua Xu,
Da Li,
Rui Chen,
Junhong Ma,
Zhao Jing,
Xidong Gu,
Hongming Pan,
and Chao He
|
22869-22879 |
Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.4412
Xian-Peng Li,
Xiao-Yu Yang,
Ewelina Biskup,
Jiang Zhou,
Hong-Liang Li,
Yi-Feng Wu,
Ming-Liang Chen,
and Feng Xu
|
22880-22889 |
Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis
Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis |
https://doi.org/10.18632/oncotarget.4413
Michael W. Pickup,
Laura D. Hover,
Yan Guo,
Agnieszka E. Gorska,
Anna Chytil,
Sergey V. Novitskiy,
Harold L. Moses,
and Philip Owens
|
22890-22904 |
In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration, inflammation and decreased adhesion
In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration, inflammation and decreased adhesion |
https://doi.org/10.18632/oncotarget.4416
Xiaopan Cai,
Jian Luo,
Xinghai Yang,
Huayun Deng,
Jishen Zhang,
Shichang Li,
Haifeng Wei,
Cheng Yang,
Leqin Xu,
Rongrong Jin,
Zhenxi Li,
Wang Zhou,
JianDong Ding,
Jianjun Chu,
Lianshun Jia,
Qi Jia,
Chengjun Tan,
Mingyao Liu,
and Jianru Xiao
|
22905-22917 |
The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis
The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis |
https://doi.org/10.18632/oncotarget.4382
Lingyun Zhang,
Yuee Teng,
Yibo Fan,
Yan Wang,
Wei Li,
Jing Shi,
Yanju Ma,
Ce Li,
Xiaonan Shi,
Xiujuan Qu,
and Yunpeng Liu
|
22918-22933 |
Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition
Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition |
https://doi.org/10.18632/oncotarget.4473
Hanbing An,
Sydney L. Stoops,
Natasha G. Deane,
Jing Zhu,
Jinghuan Zi,
Connie Weaver,
Alex G. Waterson,
Andries Zijlstra,
Craig W. Lindsley,
and Robert Daniel Beauchamp
|
22934-22948 |
Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins
Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins |
https://doi.org/10.18632/oncotarget.5146
Yihong Wang,
Lauren Ende Shwartz,
Derek Anderson,
Ming-Tseh Lin,
Lisa Haley,
Ren-chin Wu,
Russell Vang,
Ie-ming Shih,
and Robert J. Kurman
|
22949-22958 |
Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo
Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo |
https://doi.org/10.18632/oncotarget.4038
Annelie Abrahamsson,
and Charlotta Dabrosin
|
22959-22969 |
Association of the intermediate filament nestin with cancer stage: a meta-analysis based on 223 positive/high nestin cases and 460 negative/low case-free controls
Association of the intermediate filament nestin with cancer stage: a meta-analysis based on 223 positive/high nestin cases and 460 negative/low case-free controls |
https://doi.org/10.18632/oncotarget.4042
Beilong Zhong,
Tao Wang,
Jianyong Zou,
Fangfang Zheng,
Rijiao Huang,
Xiaobin Zheng,
Weilin Yang,
and Zhenguang Chen
|
22970-22977 |
Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort
Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort |
https://doi.org/10.18632/oncotarget.3938
Yao Zhu,
Cheng-Tao Han,
Hai-Tao Chen,
Fang Liu,
Gui-Ming Zhang,
Wei-Yi Yang,
Jian-Feng Xu,
and Ding-Wei Ye
|
22978-22984 |
Effect of tumor size on breast cancer-specific survival stratified by joint hormone receptor status in a SEER population-based study
Effect of tumor size on breast cancer-specific survival stratified by joint hormone receptor status in a SEER population-based study |
https://doi.org/10.18632/oncotarget.3945
Yi-Zi Zheng,
Lei Wang,
Xin Hu,
and Zhi-Ming Shao
|
22985-22995 |
MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer |
https://doi.org/10.18632/oncotarget.4035
Femke Simmer,
Sabine Venderbosch,
Jeroen R. Dijkstra,
Elisa M. Vink-Börger,
Claudius Faber,
Leonie J. Mekenkamp,
Miriam Koopman,
Anton F. De Haan,
Cornelis J. Punt,
and Iris D. Nagtegaal
|
22996-23007 |
Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect
Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect |
https://doi.org/10.18632/oncotarget.3984
Nicolas Andre,
Sylvie Cointe,
Vincent Barlogis,
Laurent Arnaud,
Romaric Lacroix,
Eddy Pasquier,
Françoise Dignat-George,
Gérard Michel,
and Florence Sabatier
|
23008-23014 |
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status |
https://doi.org/10.18632/oncotarget.4132
Matthias Dürst,
Heike Hoyer,
Christoph Altgassen,
Christiane Greinke,
Norman Häfner,
Alba Fishta,
Mieczyslaw Gajda,
Ute Mahnert,
Peter Hillemanns,
Thomas Dimpfl,
Miriam Lenhard,
K. Ulrich Petry,
Ingo B. Runnebaum,
and Achim Schneider
|
23015-23025 |
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis |
https://doi.org/10.18632/oncotarget.4854
Guohong Zhang,
Yabin Cheng,
Guangdi Chen,
Yun Tang,
Gholamreza Ardekani,
Anand Rotte,
Magdalena Martinka,
Kevin McElwee,
Xuezhu Xu,
Qi Wang,
and Youwen Zhou
|
23026-23035 |